Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide PopulationBased Study

http://www.medworm.com/index.php?rid=162213415&cid=c_64_49_f&fid=33665&url=http%3A%2F%2Fjournals.lww.com%2Fmd-journal%2FFulltext%2F2016%2F01120%2FRisks_of_Adverse_Events_Following_Coprescription.66.aspx

Comments are closed.